HKLII Hong Kong Regulations

[Index] [Table] [Search] [Notes] [Noteup] [Previous] [Next] [Download (Current & Past)] [Download (Current only)] [繁體中文] [Help]

CHINESE MEDICINES TRADERS (REGULATORY) REGULATION - SECT 2

Interpretation

In this Regulation, unless the context otherwise requires-

"Board" (中藥組) means the Chinese Medicines Board established by section
12(b) of the Ordinance;

"Board chairman" (中藥組主席) means the chairman of the Board mentioned
in section 14(a) of the Ordinance;

"Board secretary" (中藥組秘書) means the secretary of the Board appointed
under section 23(2) of the Ordinance;

"Committee" (小組) means the Regulatory Committee of Chinese Medicines
Traders established under section 25(1)(b)(iii) of the Ordinance;

"Committee chairman" (小組主席) means the chairman of the Committee
mentioned in section 31(b)(i) of the Ordinance;

"Committee secretary" (小組秘書) means the secretary of the Committee;

"complainant" (申訴人) means a person from whom a complaint or information
has been received by the Board under section 3;

"defendant" (被告人), in relation to a complaint or information, means a
licensed Chinese medicines trader in respect of whom a complaint or
information has been made;

"licensed Chinese medicines trader" (持牌中藥業者) means a Chinese
medicines trader who holds a licence to which section 139 of the Ordinance
applies.

"Board" (中藥組)

"Board chairman" (中藥組主席)

"Board secretary" (中藥組秘書)

"Committee" (小組)

"Committee chairman" (小組主席)

"Committee secretary" (小組秘書)

"complainant" (申訴人)

"defendant" (被告人)

"licensed Chinese medicines trader" (持牌中藥業者)



[Index] [Table] [Search] [Notes] [Noteup] [Previous] [Next] [Download (Current & Past)] [Download (Current only)] [繁體中文] [Help]